Xilio Therapeutics Appoints Yuan Xu, Ph.D., to its Board of Directors
Xilio Therapeutics Announces Initiation of Patient Dosing in Phase 1/2[...]
01/18/2022 | Press release | Distributed by Public on 01/18/2022 04:48
Please select the service you want to use:
Smartlinks | coinIX GmbH & Co. KgaA | News | Technology | Business and Economy | Finance | Stock Markets | Security Markets | Currency Market | Stock Markets | Security Markets | Company News | Top Company News | Financial Services | Investment Funds | Investment Services | Public Companies | Investment Companies | Börse Düsseldorf
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact